Lupus Foundation Funds New Research to Target Autoimmune Pathways

Dr. Kaien Gu, based at The Feinstein Institutes for Medical Research in New York, will focus on B cell behavior. By investigating how these cells produce autoantibodies, the research intends to clarify the fundamental triggers of lupus and identify potential targets for more precise symptom management. Meanwhile, Dr. Emma Materne from Brigham and Women's Hospital in Massachusetts will analyze blood metabolites. Her work examines how energy, fat, and protein usage patterns in lupus patients differ from those of healthy individuals, potentially offering a new method for tailoring treatments based on specific organ involvement and metabolic indicators.

Brad Rovin, chair of the foundation’s Medical-Scientific Advisory Council, noted that these projects are designed to overcome current barriers in the scientific pipeline. By supporting investigators at a critical stage in their professional development, the foundation seeks to secure the long-term future of lupus research. With approximately 1.5 million Americans currently living with the disease, the focus remains on transforming how this complex, often unpredictable condition is diagnosed and treated.